Human Genome Epidemiology Literature Finder
|
Records 1 - 7 (of 7 Records) |
| Query Trace: Sclerosis and CCL2[original query] |
|---|
| An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians. BMC medical genetics 2006 7 (): 64. Bugeja Matthew J, Booth David, Bennetts Bruce, Heard Robert, Rubio Justin, Stewart Grae |
| Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis. The Journal of rheumatology 2008 May 35 (5): 839-44. Carulli Maria Teresa, Spagnolo Paolo, Fonseca Carmen, Welsh Kenneth I, duBois Roland M, Black Carol M, Denton Christopher |
| The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patients. Human immunology 2009 Feb 70 (2): 130-3. Radstake Timothy R D J, Vonk Madelon C, Dekkers Marieke, Schijvenaars Mascha M V A P, Treppichio William L, Lafyatis Robert, Riemekasten Gabriela, van den Hoogen Frank, Coenen Marieke J |
| Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis. Genes and immunity 2010 Mar 11 (2): 142-54. Ockinger J, Stridh P, Beyeen A D, Lundmark F, Seddighzadeh M, Oturai A, Sørensen P S, Lorentzen A R, Celius E G, Leppä V, Koivisto K, Tienari P J, Alfredsson L, Padyukov L, Hillert J, Kockum I, Jagodic M, Olsson |
| Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene. Journal of immunology (Baltimore, Md. : 1950) 2009 Feb 182 (3): 1270-7. Pacheco-Rodriguez Gustavo, Kumaki Fumiyuki, Steagall Wendy K, Zhang Yi, Ikeda Yoshihiko, Lin Jing-Ping, Billings Eric M, Moss Jo |
| No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population. Tissue antigens 2014 Aug 84 (2): 223-8. Namgoong S, Bae J S, Cheong H S, Kim J-H, Kim J Y, Kim L H, Kim H J, Shin H |
| Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1 monocytes-derived macrophages. Annals of the rheumatic diseases 2024 9 . Xinran Yuan, Xiaodong Qin, Kenji Takemoto, Jian Zhao, Matthew Sanderson, Xue Xu, Yu Zhang, Kristi L Helke, Bethany Jacobs Wolf, Joel M Guthridge, Judith A James, Xiaodong Zhou, Shervin Assassi, Carol Feghali-Bostwick, Dandan Wang, Lingyun Sun, Betty P Ts |
- Page last reviewed:Feb 1, 2024
- Content source: